HIV SEROPOSITIVITY
Clinical trials for HIV SEROPOSITIVITY explained in plain language.
Never miss a new study
Get alerted when new HIV SEROPOSITIVITY trials appear
Sign up with your email to follow new studies for HIV SEROPOSITIVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to safely prevent TB in pregnant women with HIV
Disease control OngoingThis study looks at how safe and tolerable two different TB prevention treatments are for pregnant women with HIV. About 252 pregnant women will take either a daily pill for one month or a weekly pill for three months. Researchers will also check how these treatments interact wit…
Matched conditions: HIV SEROPOSITIVITY
Phase: PHASE1, PHASE2 • Sponsor: The Aurum Institute NPC • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
One-Month TB prevention pill could beat Three-Month regimen in High-Risk groups
Prevention OngoingThis study tests whether a 1-month daily TB prevention pill works as well as a 3-month weekly option in two groups: people living with HIV and HIV-negative household contacts of TB patients. About 1,000 participants in South Africa and India will be randomly assigned to one of th…
Matched conditions: HIV SEROPOSITIVITY
Phase: PHASE4 • Sponsor: The Aurum Institute NPC • Aim: Prevention
Last updated May 04, 2026 16:31 UTC